News & Publications

Representation of Check-Cap Ltd. in $35M Registered Direct Offering

Represented of Check-Cap Ltd. in a $35 million registered direct offering of ordinary shares and warrants. H.C. Wainwright & Co., LLC served as exclusive placement agent for the offering. Check-Cap, listed on NASDAQ, is a clinical stage medical diagnostics company aiming to redefine colorectal cancer (CRC) screening through the introduction of C-Scan®, the first and only patient-friendly preparation-free screening […]

Eran Yaniv & Sharon Rosen | Oct 2021 | Transaction

Representation of Check-Cap Ltd. in a Warrant Exercise Transaction

Representation of Check-Cap Ltd. in a warrant exercise transaction with several existing institutional investors who were holders of certain outstanding warrants to purchase the Company’s ordinary shares issued in prior registered direct offerings. In connection with the transaction, the holders exercised in cash their prior warrants, at a reduced exercise price of $0.6 per share. […]

Eran Yaniv & Sharon Rosen & Yuval Peled | Jan 2021 | Transaction

Representation of J.P. Morgan in the Private Offering by Fiverr International Ltd. (NYSE: FVRR) of Convertible Senior Notes

Representation of J.P. Morgan as Lead Left Bookrunner and representative of the initial purchasers in the private offering by Fiverr International Ltd. (Nasdaq: FVRR) of $460 million of 0% Convertible Senior Notes due 2025 (including the exercise in full of the overallotment option). The Notes were offered in a private offering to qualified institutional buyers […]

Eran Yaniv & Sharon Rosen & Yuval Peled & Omri Rachum-Twaig, Dr. & Gal Doitch | Jan 2021 | Transaction

Representation of Luminera Derm in the Sale of its Dermal Business to AbbVie

Representation of Luminera Derm Ltd. and its affiliated companies in a share and asset transaction, pursuant to which Luminera sold its dermal filler portfolio and R&D pipeline to AbbVie Inc. (NYSE: ABBV) unit Allergan Aesthetics, for a consideration of hundreds of millions of dollars. Luminera Derm is an R&D company as well as a manufacturer […]

Raz Tepper & Ziv Schwartz & Sharona Haim Pour - Abramovich & Yuval Peled & Ben Strauss & Audrey Abensur & Moran Friedman | Oct 2020 | Transaction

Representation of J.P. Morgan, Bank of America and Morgan Stanley in the Private Offering by Wix.com of $575 million of 0% Convertible Senior Notes

Representation of J.P. Morgan, Bank of America and Morgan Stanley as Joint Book-Running Managers in the private offering by Wix.com Ltd. (Nasdaq: WIX) of $575 million of 0% Convertible Senior Notes due 2025 (including the exercise in full of an over-allotment option granted to the initial purchasers). The Notes were offered in a private offering […]

Michael Zellermayer & Sharon Rosen & Yuval Peled | Oct 2020 | Transaction

Representation of J.P. Morgan Securities in the $138M Follow-On Offering of Fiverr International

Representation of J.P. Morgan Securities LLC as lead book-running manager in the $138 million underwritten public offering in the United Sates of Fiverr International Ltd. (including the exercise in full of the underwriters’ option). J.P. Morgan Securities LLC acted as lead book-running manager for the offering. BofA Securities, Citigroup Global Markets Inc. and UBS Securities […]

Eran Yaniv & Sharon Rosen & Liat Halperin & Omri Rachum-Twaig, Dr. & Jonathan Shtang | Sep 2020 | Transaction

Representation of AngioDynamics in the acquisition of Eximo Medical

FBC and DLA Piper represented AngioDynamics Inc., in an acquisition of Eximo Medical Ltd., an Israeli company. The transaction included extensive and sensitive negotiations of the terms and conditions of the acquisition from the various shareholders of Eximo Medical Ltd. and included the purchase of the company’s shares and treatment of the company’s options and […]

Raz Tepper & Yuval Peled & Jonathan Shtang & Moran Friedman & Omri Rachum-Twaig, Dr. | Oct 2019 | Transaction

Representation of Pitango Venture Capital in a $30 million financing of Venn Ltd

FBC represented Pitango Venture Capital that led an investment round in Venn Ltd. of up to $30 million. The investment was performed through combination of Preferred Shares and SAFE instruments. Additional investors in this round include Hamilton Lane, on behalf of the New York State Common Retirement Fund, and Bridges Israel. Venn is creating a […]

Liat Halperin & Shany Zalmanovich & Ofir Nahum Fartuk & Garance Seroussi | Jul 2019 | Transaction

Representation of J.P. Morgan and Bank of America in the $442.8 million Private Offering by Wix.com Ltd. of Convertible Senior Notes

FBC represented J.P. Morgan and Bank of America as Joint Book-Running Managers in the private offering by Wix.com Ltd. (Nasdaq: WIX) of $442.8 million of 0% Convertible Senior Notes due 2023 (including the exercise in full of an over-allotment option granted to the initial purchasers). The notes were offered in a private offering to qualified […]

Michael Zellermayer & Sharon Rosen & Dikla Nassi | Jul 2018 | Transaction

Representation of Dune Ridge Group in a Financing Transaction

FBC represented the Dune Ridge group (the group includes entities in the BVI, US and Israel) in a financing round in which it raised US$2,600,000, including a deferred closing of an additional amount of up to US$500,000.

Reuven Behar & Liat Halperin | Jun 2018 | Transaction

Representation of Check-Cap Ltd. in Follow-On Underwritten Public Offering

FBC represented Check-Cap Ltd., listed on NASDAQ, in its $20.2 million follow-on underwritten public offering of units, with each unit consisting of one ordinary share (or ordinary share equivalent) and one Series C warrant to purchase one ordinary share. H.C. Wainwright & Co. acted as sole book-running manager for the offering. Check-Cap is a clinical-stage […]

Eran Yaniv & Sharon Rosen | May 2018 | Transaction

Representation of Frutarom Industries Ltd. in its Acquisition of Enzymotec Ltd.

FBC represented Frutarom Industries Ltd. in its acquisition of Enzymotec Ltd. (NASD: ENZY), for approximately $210 million, at an equity value of approximately $290 million. Enzymotec is a leading global supplier of specialty lipid-based products and solutions. Prior to the merger, Frutarom had acquired approximately 19% of Enzymotec’s shares and announced its intention to make […]

Avraham Well & Sharon Rosen & Zohar Liss & Ziv Schwartz & Moran Friedman & Hilla Sachs | Jan 2018 | Transaction

FBC advises InfiApps in its $39.2M acquisition by Stride Gaming

Eran Yaniv & Liat Halperin & Amit Dat | Aug 2015 | Transaction

FBC advises Qualcomm in its acquisition of Wilocity for approximately $400M

Raz Tepper & Moran Friedman | Jul 2014 | Transaction

FBC advises Qualcomm in its acquisition of CSR’s imaging unit for approximately $45M

Raz Tepper & Ronald Lehmann & Amit Dat & Moran Friedman & Ziv Schwartz | Jul 2014 | Transaction